Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07368946 · ClinicalTrials.gov registry record · NA
Phosphate Assessment in Chronic Kidney Disease Patients Study
A NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT07368946: Recruiting NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder, sponsored by University of Texas Southwestern Medical Center.
NCT07368946 is a NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07368946, a NA study of Chronic Kidney Disease (Stage 3-4) and Chronic Kidney Disease Mineral and Bone Disorder, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability. Investigators will address the following specific aims: 1). To explore novel pathways of phosphate metabolism and assess the influence of CKD status on these metabolic pathways. 2). To identify novel biomarkers for phosphate overload that reflect changes in dietary phosphorus intake. 3). To develop a compound phosphate overload index that measures dietary phosphorus intake with high validity and reliability. This study will provide novel insights into phosphate metabolism and the assessment of phosphate overload in CKD patients. This investigation aims to provide preliminary data to further studies for the development of reliable biomarkers in CKD patients, which could contribute significantly to early interventions and improve health outcomes.
Primary Outcome
Circulating serum phosphate levels (mg/dL) will be measured using standard clinical laboratory assays
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Dietary Phosphorus Intake
Study Locations (1)
Texas
- University of Texas Southwestern Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2025-05-09 |
| Est. Completion | 2026-12-31 |
| Phase | NA |
What NCT07368946 shows while recruiting
NCT07368946 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 2 conditions, with Chronic Kidney Disease (Stage 3-4) appearing as the primary indexed condition, and to 1 intervention - of which Dietary Phosphorus Intake is the first listed.
NCT07368946 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT07368946 about?
NCT07368946 is a clinical study titled "Phosphate Assessment in Chronic Kidney Disease Patients Study". The proposed pilot feeding study aims to explore novel pathways in phosphate metabolism and identify new biomarkers, as well as to develop a compound index for assessing phosphate overload with high validity and reliability. Investigators will address the following specific aims: 1). To explore nov...
What is the current status of trial NCT07368946?
This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2025-05-09. Estimated completion is 2026-12-31.
What conditions does trial NCT07368946 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (Stage 3-4), Chronic Kidney Disease Mineral and Bone Disorder.
What interventions are being tested in trial NCT07368946?
The interventions under investigation include: Dietary Phosphorus Intake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07368946?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07368946 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Disease (Stage 3-4)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07368946's enrollment target sits among peer trials
60 1164th of 2000 higher than 745 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI